These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33761688)

  • 1. Efficacy and safety of qiming granule combined with laser in the treatment of diabetic retinopathy: A protocol of randomized controlled trial.
    Zhou C; Long B; Huang W; Jiang L
    Medicine (Baltimore); 2021 Mar; 100(12):e25158. PubMed ID: 33761688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of qiming granule for diabetic macular edema: A protocol for systematic review and meta-analysis.
    Hu Z; Yang M; Xie C; Gao H; Fu X; Xie H; Liu Y
    Medicine (Baltimore); 2019 Oct; 98(42):e17496. PubMed ID: 31626104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laser photocoagulation for proliferative diabetic retinopathy.
    Evans JR; Michelessi M; Virgili G
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD011234. PubMed ID: 25420029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of qiming granule on retinal blood circulation of diabetic retinopathy: a multicenter clinical trial.
    Luo XX; Duan JG; Liao PZ; Wu L; Yu YG; Qiu B; Wang YL; Li YM; Yin ZQ; Liu XL; Yao K
    Chin J Integr Med; 2009 Oct; 15(5):384-8. PubMed ID: 19802544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standard threshold laser versus subthreshold micropulse laser for adults with diabetic macular oedema: the DIAMONDS non-inferiority RCT.
    Lois N; Campbell C; Waugh N; Azuara-Blanco A; Maredza M; Mistry H; McAuley D; Acharya N; Aslam TM; Bailey C; Chong V; Downey L; Eleftheriadis H; Fatum S; George S; Ghanchi F; Groppe M; Hamilton R; Menon G; Saad A; Sivaprasad S; Shiew M; Steel DH; Talks JS; Doherty P; McDowell C; Clarke M
    Health Technol Assess; 2022 Dec; 26(50):1-86. PubMed ID: 36541393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Add-on effect of Qiming granule, a Chinese patent medicine, in treating diabetic macular edema: A systematic review and meta-analysis.
    Hu Z; Xie C; Yang M; Fu X; Gao H; Liu Y; Xie H
    Phytother Res; 2021 Feb; 35(2):587-602. PubMed ID: 32939932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
    Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
    JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.
    Lam DS; Chan CK; Mohamed S; Lai TY; Lee VY; Liu DT; Li KK; Li PS; Shanmugam MP
    Ophthalmology; 2007 Dec; 114(12):2162-7. PubMed ID: 17459479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microperimetry and fundus autofluorescence in diabetic macular edema: subthreshold micropulse diode laser versus modified early treatment diabetic retinopathy study laser photocoagulation.
    Vujosevic S; Bottega E; Casciano M; Pilotto E; Convento E; Midena E
    Retina; 2010 Jun; 30(6):908-16. PubMed ID: 20168272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial.
    Sivaprasad S; Prevost AT; Vasconcelos JC; Riddell A; Murphy C; Kelly J; Bainbridge J; Tudor-Edwards R; Hopkins D; Hykin P;
    Lancet; 2017 Jun; 389(10085):2193-2203. PubMed ID: 28494920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravitreal ranibizumab alone or in combination with panretinal photocoagulation for the treatment of proliferative diabetic retinopathy with coexistent macular edema: long-term outcomes of a prospective study.
    Chatziralli I; Dimitriou E; Theodossiadis G; Kazantzis D; Theodossiadis P
    Acta Diabetol; 2020 Oct; 57(10):1219-1225. PubMed ID: 32472172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.
    Diabetic Retinopathy Clinical Research Network
    Ophthalmology; 2008 Sep; 115(9):1447-9, 1449.e1-10. PubMed ID: 18662829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
    Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
    Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monotherapy laser photocoagulation for diabetic macular oedema.
    Jorge EC; Jorge EN; Botelho M; Farat JG; Virgili G; El Dib R
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD010859. PubMed ID: 30320466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser therapy for retinopathy in sickle cell disease.
    Myint KT; Sahoo S; Thein AW; Moe S; Ni H
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010790. PubMed ID: 26451693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized trial of peribulbar triamcinolone acetonide with and without focal photocoagulation for mild diabetic macular edema: a pilot study.
    ; Chew E; Strauber S; Beck R; Aiello LP; Antoszyk A; Bressler N; Browning D; Danis R; Fan J; Flaxel C; Friedman S; Glassman A; Kollman C; Lazarus H
    Ophthalmology; 2007 Jun; 114(6):1190-6. PubMed ID: 17544778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ETDRS panretinal photocoagulation combined with intravitreal ranibizumab versus PASCAL panretinal photocoagulation with intravitreal ranibizumab versus intravitreal ranibizumab alone for the treatment of proliferative diabetic retinopathy.
    Barroso RMP; Messias K; Garcia DM; Cardillo JA; Scott IU; Messias A; Jorge R
    Arq Bras Oftalmol; 2020; 83(6):526-534. PubMed ID: 33470281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of various laser intervention strategies for proliferative diabetic retinopathy.
    Luo D; Zheng Z; Xu X; Fan Y; Zhu B; Liu K; Wang F; Sun X; Zou H; Xia X
    Expert Rev Med Devices; 2015 Jan; 12(1):83-91. PubMed ID: 25154790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
    Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravitreal triamcinolone combined with grid laser photocoagulation for patients with cystoid macular edema and advanced diabetic retinopathy: pilot study].
    Arévalo JF; Fernández CF; Mendoza AJ; García RA; Arévalo FA
    Arch Soc Esp Oftalmol; 2013 Oct; 88(10):373-9. PubMed ID: 24060300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.